Close Menu

DNAnexus

DNANexus has hired Ken Kershner to serve as its vice president of engineering.

DNAnexus has launched a developer program that offers bioinformaticians and software engineers the technical and support resources needed to create and integrate data analysis applications on its platform.

Enzymatics has launched SPARK sample prep kits for Illumina and Life Technologies' Ion Torrent sequencing platforms.

This week, Firefly BioWorks released PubmiR, a free search engine for microRNA pathways.

Developers of InSilico DB, a publicly available repository of genomic datasets, are preparing to offer a commercial service based on the resource that will offer paying customers the chance to compare their proprietary RNA sequence data with public information and analyze it usin

Maverix Biomics, a San Mateo, Calif.-based bioinformatics startup, this week launched the first version of the Maverix Analytic Platform, a cloud-based offering for next-generation sequence data management, exploration, and visualization.

Emerging from stealth mode, newly minted Five3 Genomics is hoping to claim a share of the bioinformatics marketplace by providing cancer genome analysis services using tools developed at the University of California, Santa Cruz.

Rubicon Genomics has hired Kenneth Solomon as director of sales and marketing. He has previously held positions at Centocor Ortho Biotech, Pharmacia/Searle, Biomet, and Boehringer Manheim.

DNANexus has appointed Marc Olesen to serve as president and chief operating officer.

Bioinformatics startup Omicia has appointed Leroy Hood and Paul Flicek to its scientific advisory board.

Pages

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.